Suchergebnisse - "Rebold, Nicholas"

PubPharm (28)

1

Updates in pulmonary drug-resistant tuberculosis pharmacotherapy : A focus on BPaL and BPaLM

enthalten in: Pharmacotherapy | 2024

von Holger, D. | Althubyani, A. | Morrisette, T. | +2

2

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection : A Multicenter Observational Study

enthalten in: Infectious diseases and therapy | 2024

von Rebold, N. | Alosaimy, S. | Pearson, J. | +21

3

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

enthalten in: Infectious diseases and therapy | 2024

von Rebold, N. | Alosaimy, S. | Pearson, J. | +21

4

Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy : A focus on BPaL and BPaLM

enthalten in: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | 2024

von Holger, D. | Althubyani, A. | Morrisette, T. | +2

5

Oral stepdown in Gram-positive bloodstream infections : A step in the right direction

enthalten in: Pharmacotherapy | 2023

von Caniff, K. | Rebold, N. | Rybak, M.

6

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

enthalten in: Open forum infectious diseases | 2023

von Kunz Coyne, A. | El Ghali, A. | Lucas, K. | +5

7

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

enthalten in: Microbiology spectrum | 2023

von Rebold, N. | Lagnf, A. | Alosaimy, S. | +10

8

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents : Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Alosaimy, S. | Lagnf, A. | Hobbs, A. | +30

CommentIn: Clin Infect Dis. 2023 Apr 17;76(8):1521-1522. - PMID 36550021

9

Oral stepdown in Gram‐positive bloodstream infections : A step in the right direction

enthalten in: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | 2023

von Caniff, K. | Rebold, N. | Rybak, M.

10

Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

enthalten in: Infectious diseases and therapy | 2022

von Holger, D. | Rebold, N. | Alosaimy, S. | +7